View Older Stories

May 8, 2026 12:04PM Health officials explore restrictions on certain SSRI antidepressants - Reuters

May 5, 2026 08:05AM AbbVie presents inflammatory bowel disease data at medical conference

Apr 30, 2026 06:59AM Abbvie (ABBV) PT Raised to $265 at Canaccord

Apr 30, 2026 06:11AM BofA Securities Upgrades Abbvie (ABBV) to Buy

Apr 30, 2026 04:25AM Abbvie (ABBV) PT Raised to $244 at Goldman Sachs

Apr 29, 2026 07:48AM AbbVie (ABBV) Tops Q1 EPS by 6c, Beats on Revenue; Offers FY26 EPS Guidance

Apr 29, 2026 12:00AM AbbVie Q1 earnings preview: analysts eye immunology growth trends

Apr 28, 2026 07:01AM EvolveImmune receives $18 million milestone payment from ABBV partnership

Apr 27, 2026 08:05AM AbbVie submits FDA application for SKYRIZI subcutaneous dosing

Apr 23, 2026 04:06PM FDA requests more manufacturing data for AbbVie's botox alternative

Apr 23, 2026 09:20AM Abbvie (ABBV) PT Lowered to $294 at Piper Sandler

Apr 22, 2026 12:28PM AbbVie to build $1.4 billion manufacturing campus in North Carolina

Apr 20, 2026 04:36PM Canaccord Starts Abbvie (ABBV) at Buy, PT set at $262

Apr 13, 2026 05:52AM Bernstein on US Pharma and Biotech: Who might buy whom?

Apr 10, 2026 08:36AM RBC Capital Reiterates Outperform Rating on Abbvie (ABBV)

Apr 10, 2026 06:57AM Abbvie (ABBV) PT Raised to $249 at Guggenheim

Apr 8, 2026 07:31AM Abbvie (ABBV) PT Lowered to $240 at Cantor Fitzgerald on Bad Sentiment

Mar 30, 2026 08:01AM Allergan Aesthetics presents data on investigational neurotoxin at AAD

Mar 26, 2026 05:45AM Allergan Aesthetics presents 21 research posters at Monaco medical congress

Mar 18, 2026 09:21AM RBC Capital on Biopharma: 'M&A Discussion, Whether Accurate Or Not, Can Drive Returns'

Mar 12, 2026 06:55AM Guggenheim Reiterates Buy Rating on Abbvie (ABBV)

Mar 9, 2026 11:52AM William Blair Reiterates Outperform Rating on Abbvie (ABBV): "competitive across the amylin class"

Mar 9, 2026 09:35AM BMO Capital Reiterates Outperform Rating on Abbvie (ABBV): today's data "reflective of an opportunity to diversify its business beyond the I&I"

Feb 25, 2026 06:04AM AbbVie (ABBV) 7-Part Filing

Feb 24, 2026 04:07PM RBC Capital Starts Abbvie (ABBV) at Outperform

Feb 23, 2026 11:00AM AbbVie plans $380 million manufacturing expansion in North Chicago

Feb 20, 2026 06:00AM Barclays Starts Abbvie (ABBV) at Overweight

Feb 20, 2026 05:29AM FDA approves AbbVie's VENCLEXTA-acalabrutinib combo for untreated CLL

Feb 19, 2026 09:38AM AbbVie (ABBV) Declares $1.73 Quarterly Dividend; 3% Yield

Feb 5, 2026 10:17AM Cantor Fitzgerald Reiterates Overweight Rating on Abbvie (ABBV)

Feb 5, 2026 07:36AM Bernstein: 'We Anticipate Abbvie (ABBV) To Be Down MSD Today'

Feb 4, 2026 02:21PM Abbvie (ABBV) PT Lowered to $228 at Evercore ISI

Feb 4, 2026 10:36AM AbbVie (ABBV) executive: Abbvie: peak sales for Parkinson's and migraine franchises could exceed $5 billion

Feb 4, 2026 08:04AM AbbVie beats Q4 expectations, shares dip

Feb 4, 2026 07:51AM AbbVie (ABBV) Tops Q4 EPS by 6c, Beats on Revenue; Offers FY26 EPS Guidance

Feb 3, 2026 06:00PM AbbVie earnings preview: Bernstein expects another tightly framed outlook

Feb 3, 2026 08:02AM AbbVie submits vitiligo treatment application to FDA and EMA

Feb 2, 2026 05:12AM AbbVie (ABBV) call put ratio 2.3 calls to 1 put into quarter results

Jan 28, 2026 06:57AM Goldman Sachs Reiterates Neutral Rating on Abbvie (ABBV) Ahead of Earnings

Jan 27, 2026 04:48PM Eli Lilly, Pfizer, AbbVie drugs targeted in third Medicare price talks

Jan 21, 2026 10:00AM This U.S. biotech stock is Bernstein's Top Pick for 2026

Jan 20, 2026 09:31AM Bernstein Reiterates Market Perform Rating on Abbvie (ABBV)

Jan 15, 2026 08:25AM BMO Capital Reiterates Outperform Rating on Abbvie (ABBV)

Jan 13, 2026 10:07AM UBS Reiterates Neutral Rating on Abbvie (ABBV)

Jan 12, 2026 06:35PM AbbVie (ABBV) and Trump Administration Reach Agreement To Cut Drug Prices, $100 bln Investment

Jan 12, 2026 07:30AM AbbVie licenses cancer drug from RemeGen for $650 million upfront

Jan 9, 2026 07:46AM HSBC lists 11 potential U.S. outperformers heading into earnings

Jan 8, 2026 03:44PM Merck (MRK) in Talks to buy Revolution Medicines (RVMD) - FT

Jan 8, 2026 11:22AM AbbVie (ABBV) call put ratio 1.3 calls to 1 put into the annual J.P. Morgan Healthcare Conference

Jan 8, 2026 08:39AM Merck upgraded on post-Keytruda growth, AbbVie cut as upside baked in - Wolfe

View Older Stories